Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the...
Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering
SellerSwitch Ltd.’s Investment Round
Gessel advised Fulfilio on the deal. Fulfilio completed an investment in SellerSwitch. The investment involved the acquisition of a majority stake from the existing shareholders, which opens...
Krones’ Acquisition of Netstal Maschinen From KraussMaffei
Lenz & Staehelin advised Krones in this transaction. Krones AG agreed to acquire all shares in Netstal Maschinen AG from KraussMaffei. Netstal is a leading supplier...
Arlington Capital Partners VI Fund’s Closing at $3.8 Billion
Kirkland & Ellis advised Arlington Capital Partners on the deal. Arlington Capital Partners (“Arlington”) announced the close of its latest fund, Arlington Capital Partners VI (“Fund...